<VariationArchive VariationID="664624" VariationName="NM_001111.5(ADAR):c.3363dup (p.Lys1122Ter)" VariationType="Duplication" Accession="VCV000664624" Version="8" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-05-08" DateCreated="2019-08-14" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="626874" VariationID="664624">
      <GeneList>
        <Gene Symbol="ADAR" FullName="adenosine deaminase RNA specific" GeneID="103" HGNC_ID="HGNC:225" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1q21.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="154582057" stop="154627997" display_start="154582057" display_stop="154627997" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="154554532" stop="154600455" display_start="154554532" display_stop="154600455" Strand="-" />
          </Location>
          <OMIM>146920</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001111.5(ADAR):c.3363dup (p.Lys1122Ter)</Name>
      <CanonicalSPDI>NC_000001.11:154585296:A:AA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>1q21.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="154557772" stop="154557773" display_start="154557772" display_stop="154557773" variantLength="1" positionVCF="154557772" referenceAlleleVCF="T" alternateAlleleVCF="TA" />
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="154585296" stop="154585297" display_start="154585296" display_stop="154585297" variantLength="1" positionVCF="154585296" referenceAlleleVCF="T" alternateAlleleVCF="TA" />
      </Location>
      <ProteinChange>K1077*</ProteinChange>
      <ProteinChange>K1122*</ProteinChange>
      <ProteinChange>K827*</ProteinChange>
      <ProteinChange>K1131*</ProteinChange>
      <ProteinChange>K1096*</ProteinChange>
      <ProteinChange>K801*</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1212t1" sequenceAccession="LRG_1212t1" change="c.3363dup">
            <Expression>LRG_1212t1:c.3363dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1212p1" sequenceAccession="LRG_1212p1" change="p.Lys1122Ter">
            <Expression>LRG_1212p1:p.Lys1122Ter</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1212" sequenceAccession="LRG_1212" change="g.51264dup">
            <Expression>LRG_1212:g.51264dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.154557773dup" Assembly="GRCh37">
            <Expression>NC_000001.10:g.154557773dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.154585297dup" Assembly="GRCh38">
            <Expression>NC_000001.11:g.154585297dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011844.2" sequenceAccession="NG_011844" sequenceVersion="2" change="g.51264dup">
            <Expression>NG_011844.2:g.51264dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001025107.3" sequenceAccession="NM_001025107" sequenceVersion="3" change="c.2478dup">
            <Expression>NM_001025107.3:c.2478dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001020278.1" sequenceAccession="NP_001020278" sequenceVersion="1" change="p.Lys827Ter">
            <Expression>NP_001020278.1:p.Lys827Ter</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001111.5" sequenceAccession="NM_001111" sequenceVersion="5" change="c.3363dup" MANESelect="true">
            <Expression>NM_001111.5:c.3363dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001102.3" sequenceAccession="NP_001102" sequenceVersion="3" change="p.Lys1122Ter">
            <Expression>NP_001102.3:p.Lys1122Ter</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001193495.2" sequenceAccession="NM_001193495" sequenceVersion="2" change="c.2478dup">
            <Expression>NM_001193495.2:c.2478dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001180424.1" sequenceAccession="NP_001180424" sequenceVersion="1" change="p.Lys827Ter">
            <Expression>NP_001180424.1:p.Lys827Ter</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001365045.1" sequenceAccession="NM_001365045" sequenceVersion="1" change="c.3390dup">
            <Expression>NM_001365045.1:c.3390dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001351974.1" sequenceAccession="NP_001351974" sequenceVersion="1" change="p.Lys1131Ter">
            <Expression>NP_001351974.1:p.Lys1131Ter</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001365046.1" sequenceAccession="NM_001365046" sequenceVersion="1" change="c.2478dup">
            <Expression>NM_001365046.1:c.2478dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001351975.1" sequenceAccession="NP_001351975" sequenceVersion="1" change="p.Lys827Ter">
            <Expression>NP_001351975.1:p.Lys827Ter</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001365047.1" sequenceAccession="NM_001365047" sequenceVersion="1" change="c.2478dup">
            <Expression>NM_001365047.1:c.2478dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001351976.1" sequenceAccession="NP_001351976" sequenceVersion="1" change="p.Lys827Ter">
            <Expression>NP_001351976.1:p.Lys827Ter</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001365048.1" sequenceAccession="NM_001365048" sequenceVersion="1" change="c.2478dup">
            <Expression>NM_001365048.1:c.2478dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001351977.1" sequenceAccession="NP_001351977" sequenceVersion="1" change="p.Lys827Ter">
            <Expression>NP_001351977.1:p.Lys827Ter</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001365049.1" sequenceAccession="NM_001365049" sequenceVersion="1" change="c.2400dup">
            <Expression>NM_001365049.1:c.2400dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001351978.1" sequenceAccession="NP_001351978" sequenceVersion="1" change="p.Lys801Ter">
            <Expression>NP_001351978.1:p.Lys801Ter</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_015840.4" sequenceAccession="NM_015840" sequenceVersion="4" change="c.3285dup">
            <Expression>NM_015840.4:c.3285dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_056655.3" sequenceAccession="NP_056655" sequenceVersion="3" change="p.Lys1096Ter">
            <Expression>NP_056655.3:p.Lys1096Ter</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_015841.4" sequenceAccession="NM_015841" sequenceVersion="4" change="c.3228dup">
            <Expression>NM_015841.4:c.3228dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_056656.3" sequenceAccession="NP_056656" sequenceVersion="3" change="p.Lys1077Ter">
            <Expression>NP_056656.3:p.Lys1077Ter</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1571046959" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001111.5(ADAR):c.3363dup (p.Lys1122Ter) AND multiple conditions" Accession="RCV000822752" Version="6">
        <ClassifiedConditionList TraitSetID="12862">
          <ClassifiedCondition DB="MedGen" ID="C3539013">Aicardi-Goutieres syndrome 6</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0406775">Symmetrical dyschromatosis of extremities</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-08-22" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001111.5(ADAR):c.3363dup (p.Lys1122Ter) AND Aicardi-Goutieres syndrome 6" Accession="RCV002290472" Version="3">
        <ClassifiedConditionList TraitSetID="9123">
          <ClassifiedCondition DB="MedGen" ID="C3539013">Aicardi-Goutieres syndrome 6</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-04-11" SubmissionCount="2">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-04-11" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2019-08-14" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">22974014</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25982145</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">29536976</ID>
        </Citation>
        <DescriptionHistory Dated="2022-10-13">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9123" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17540" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Aicardi-Goutieres syndrome 6</ElementValue>
                <XRef ID="MONDO:0014007" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">AGS6</ElementValue>
                <XRef Type="MIM" ID="615010" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15894" />
                <XRef ID="15894" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Most characteristically, Aicardi-Goutières syndrome (AGS) manifests as an early-onset encephalopathy that usually, but not always, results in severe intellectual and physical disability. A subgroup of infants with AGS present at birth with abnormal neurologic findings, hepatosplenomegaly, elevated liver enzymes, and thrombocytopenia, a picture highly suggestive of congenital infection. Otherwise, most affected infants present at variable times after the first few weeks of life, frequently after a period of apparently normal development. Typically, they demonstrate the subacute onset of a severe encephalopathy characterized by extreme irritability, intermittent sterile pyrexias, loss of skills, and slowing of head growth. Over time, as many as 40% develop chilblain skin lesions on the fingers, toes, and ears. It is becoming apparent that atypical, sometimes milder, cases of AGS exist, and thus the true extent of the phenotype associated with pathogenic variants in the AGS-related genes is not yet known.</Attribute>
                <XRef ID="NBK1475" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301648</ID>
                <ID Source="BookShelf">NBK1475</ID>
              </Citation>
              <XRef ID="51" DB="Orphanet" />
              <XRef ID="C3539013" DB="MedGen" />
              <XRef ID="MONDO:0014007" DB="MONDO" />
              <XRef Type="MIM" ID="615010" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="12862" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1125" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Symmetrical dyschromatosis of extremities</ElementValue>
                <XRef ID="Dyschromatosis+Symmetrica+Hereditaria+1/2371" DB="Genetic Alliance" />
                <XRef ID="239085000" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Dyschromatosis symmetrica hereditaria 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Dyschromatosis symmetrica hereditaria</ElementValue>
                <XRef ID="MONDO:0007483" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Familial reticulate acropigmentation of Dohi</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Reticulate acropigmentation of Dohi</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Symmetric dyschromatosis of the extremities</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">DSH1</ElementValue>
                <XRef Type="MIM" ID="127400" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">DSH</ElementValue>
                <XRef Type="MIM" ID="127400" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">RAD</ElementValue>
                <XRef Type="MIM" ID="127400" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="334" />
                <XRef ID="334" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="41" DB="Orphanet" />
              <XRef ID="C0406775" DB="MedGen" />
              <XRef ID="MONDO:0007483" DB="MONDO" />
              <XRef Type="MIM" ID="127400" DB="OMIM" />
            </Trait>
            <Trait ID="17540" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Aicardi-Goutieres syndrome 6</ElementValue>
                <XRef ID="MONDO:0014007" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">AGS6</ElementValue>
                <XRef Type="MIM" ID="615010" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15894" />
                <XRef ID="15894" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Most characteristically, Aicardi-Goutières syndrome (AGS) manifests as an early-onset encephalopathy that usually, but not always, results in severe intellectual and physical disability. A subgroup of infants with AGS present at birth with abnormal neurologic findings, hepatosplenomegaly, elevated liver enzymes, and thrombocytopenia, a picture highly suggestive of congenital infection. Otherwise, most affected infants present at variable times after the first few weeks of life, frequently after a period of apparently normal development. Typically, they demonstrate the subacute onset of a severe encephalopathy characterized by extreme irritability, intermittent sterile pyrexias, loss of skills, and slowing of head growth. Over time, as many as 40% develop chilblain skin lesions on the fingers, toes, and ears. It is becoming apparent that atypical, sometimes milder, cases of AGS exist, and thus the true extent of the phenotype associated with pathogenic variants in the AGS-related genes is not yet known.</Attribute>
                <XRef ID="NBK1475" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301648</ID>
                <ID Source="BookShelf">NBK1475</ID>
              </Citation>
              <XRef ID="51" DB="Orphanet" />
              <XRef ID="C3539013" DB="MedGen" />
              <XRef ID="MONDO:0014007" DB="MONDO" />
              <XRef Type="MIM" ID="615010" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5041500" SubmissionDate="2022-10-06" DateLastUpdated="2022-10-15" DateCreated="2022-10-15">
        <ClinVarSubmissionID localKey="NM_001111.5:c.3363dup|OMIM:615010" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002580590" DateUpdated="2022-10-15" DateCreated="2022-10-15" Type="SCV" Version="1" SubmitterName="MGZ Medical Genetics Center" OrgID="255845" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-01-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ADAR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001111.5:c.3363dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="615010" Type="MIM" />
          </Trait>
        </TraitSet>
        <Comment>ACMG criteria applied: PVS1, PM2_SUP</Comment>
        <SubmissionNameList>
          <SubmissionName>SUB12035528</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7576500" SubmissionDate="2023-10-18" DateLastUpdated="2023-10-28" DateCreated="2023-10-28">
        <ClinVarSubmissionID localKey="NM_001111.5:c.3363dup|OMIM:615010" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004050324" DateUpdated="2023-10-28" DateCreated="2023-10-28" Type="SCV" Version="1" SubmitterName="Genome-Nilou Lab" OrgID="507598" OrganizationCategory="laboratory" OrgAbbreviation="Genome Nilou" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-04-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>no</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ADAR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001111.5:c.3363dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="615010" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13910671</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1857947" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2019-08-14">
        <ClinVarSubmissionID localKey="4818855|MedGen:C3539013;C0406775" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000963568" DateUpdated="2024-02-28" DateCreated="2019-08-14" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-08-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">25982145</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">29536976</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22974014</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 664624). This premature translational stop signal has been observed in individual(s) with dyschromatosis symmetrica hereditaria (PMID: 25982145, 29536976). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Lys1122*) in the ADAR gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ADAR are known to be pathogenic (PMID: 22974014).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ADAR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000001.10:g.154557772_154557773insA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3539013" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0406775" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14224806</SubmissionName>
          <SubmissionName>SUB5371970</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5041500" TraitType="Disease" MappingType="XRef" MappingValue="615010" MappingRef="OMIM">
        <MedGen CUI="C3539013" Name="Aicardi-Goutieres syndrome 6" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7576500" TraitType="Disease" MappingType="XRef" MappingValue="615010" MappingRef="OMIM">
        <MedGen CUI="C3539013" Name="Aicardi-Goutieres syndrome 6" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1857947" TraitType="Disease" MappingType="XRef" MappingValue="C3539013" MappingRef="MedGen">
        <MedGen CUI="C3539013" Name="Aicardi-Goutieres syndrome 6" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1857947" TraitType="Disease" MappingType="XRef" MappingValue="C0406775" MappingRef="MedGen">
        <MedGen CUI="C0406775" Name="Symmetrical dyschromatosis of extremities" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

